CBD’s newly minted status as a health and wellness product, where it’s treated as a
lifestyle oil that relieves pain, fights inflammation and provides consumers with a general sense of well-being, all without the “high” effects that can come with CBD’s sister extract, THC. Until recently, cannabis was looked at as medicinal- or adult-use. With CBD, a third cannabis category — wellness — is emerging.
It’s even catching the eye of retail analysts at Wall Street firms such as Piper Jaffray. Recognizing that stores, such as Sephora, are now dedicating significant shelf space to CBD, one analyst said that she expects to see a lot of growth in theAs the CBD market grows, it will pave the way for THC products . Today, cannabis companies can establish relationships with retailers and build brand awareness with consumers through CBD.
For now, CBD is being infused into face creams, bath bombs, makeup and dozens of pet products. Proponents say it works on everything from to aching joints, relieves anxiety and skin conditions, and relaxes and rejuvenates all parts of the body. A large part of this expanding category is the edibles market, where CBD is being touted as a
I am on board with CBD are you?
Unfortunately, Gottleib resigned yesterday. Hopefully his successor will still want to find a pathway for approval for CBD products.
Look Motso187
just wait till there is a federal tax on that.
and we are not allowed to purchase it in South Dakota🙁
Even agrees, Shalini_bh
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
더 많은 것을 읽으십시오 »
Cannabis stocks mostly higher after FDA head promises April talks on CBD regulationCannabis stocks were mostly higher Thursday, as investors digested the latest earnings reports from the sector and comments from the head of the U.S. Food and Drug Administration on plans for regulation of CBD. I'm all about $NBEV at 5.00 :)
더 많은 것을 읽으십시오 »
Martha Stewart to advise cannabis companyCanadian cannabis company Canopy Growth is adding Martha Stewart as an advisor. She'll help the company develop CBD and hemp products for people and pets. Convicted felon I see you MarthaStewart
더 많은 것을 읽으십시오 »
Regulators are gearing up to decide how to handle the $1 billion CBD industry, whose lotions and cookies currently exist in a legal hazeAt a congressional hearing this week, regulators said they planned to discuss their approach to policing the $1 billion CBD industry in April.
더 많은 것을 읽으십시오 »